These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 9337534)
1. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer. Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534 [TBL] [Abstract][Full Text] [Related]
2. [The prognostic value of cytokeratin 19 expression in non-small cell lung cancer]. Kosacka M; Jankowska R Pneumonol Alergol Pol; 2007; 75(4):317-23. PubMed ID: 18080980 [TBL] [Abstract][Full Text] [Related]
3. Serum and tissue distribution of a fragment of cytokeratin 19 (cyfra 21-1) in lung cancer patients. Quillien V; Ramee MP; Bansard JY; Meritte H; Briens E; Logeais Y; Langanay T; Corbineau H; Dazord L Anticancer Res; 1995; 15(6B):2857-63. PubMed ID: 8669879 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951 [TBL] [Abstract][Full Text] [Related]
5. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas. Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220 [TBL] [Abstract][Full Text] [Related]
6. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers. Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569 [TBL] [Abstract][Full Text] [Related]
7. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation. Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576 [TBL] [Abstract][Full Text] [Related]
8. Pathology of non-small cell lung cancer. New diagnostic approaches. Linnoila I Hematol Oncol Clin North Am; 1990 Dec; 4(6):1027-51. PubMed ID: 1962774 [TBL] [Abstract][Full Text] [Related]
9. HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test. Scheurle D; Jahanzeb M; Aronsohn RS; Watzek L; Narayanan R Anticancer Res; 2000; 20(3B):2091-6. PubMed ID: 10928158 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer. Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030 [TBL] [Abstract][Full Text] [Related]
11. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320 [TBL] [Abstract][Full Text] [Related]
12. [Cyfra 21-1--a new tumor marker of the cytokeratin series in differential diagnosis of lung diseases]. Oremek GM; Seiffert UB; Siekmeier R; Kirsten R Med Klin (Munich); 1995 Jan; 90(1):23-6. PubMed ID: 7533887 [TBL] [Abstract][Full Text] [Related]
13. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis. van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278 [TBL] [Abstract][Full Text] [Related]
14. Combined large cell neuroendocrine, small cell and squamous carcinomas of the lung with rhabdoid cells. Chetty R Pathology; 2000 Aug; 32(3):209-12. PubMed ID: 10968398 [TBL] [Abstract][Full Text] [Related]
15. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment. Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405 [TBL] [Abstract][Full Text] [Related]
16. Tissue polypeptide specific antigen (tps) and cytokeratin 19 fragment (CYFRA 21.1) immunoradiometric assay in non small cell lung cancer evaluation. Giovanella L; Ceriani L; Bandera M; Rimoldi R; Beghé B; Roncari G Q J Nucl Med; 1995 Dec; 39(4):285-9. PubMed ID: 8624791 [TBL] [Abstract][Full Text] [Related]
17. Activity and tissue localization of cathepsin D in non small cell lung cancer. Chyczewski L; Płoński A; Chyczewska E; Furman M; Ostrowska H; Nikliński J; Kozłowski M Rocz Akad Med Bialymst; 1997; 42 Suppl 1():217-29. PubMed ID: 9337539 [TBL] [Abstract][Full Text] [Related]
18. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas. Sato T; Murakumo Y; Hagiwara S; Jijiwa M; Suzuki C; Yatabe Y; Takahashi M Pathol Int; 2007 Nov; 57(11):719-24. PubMed ID: 17922683 [TBL] [Abstract][Full Text] [Related]
19. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis. Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of CYFRA 21-1 in malignant and benign pleural effusions. Toumbis M; Rasidakis A; Passalidou E; Kalomenidis J; Alchanatis M; Orphanidou D; Jordanoglou J Anticancer Res; 1996; 16(4A):2101-4. PubMed ID: 8712750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]